Product Code: GVR-2-68038-553-3
Prosthetics And Orthotics Market Growth & Trends:
The global prosthetics and orthotics market size is expected to reach USD 8.48 billion by 2030, registering a CAGR of 4.4% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rising occurrence of osteosarcoma, growing geriatric population, and increasing incidences of sports injuries are the key factors driving the market growth. For instance, in 2023, according to the American Cancer Society's estimates, 3,970 new cases were diagnosed with primary cancer of the bones and joints.
Globally, increasing geriatric population is the major factor driving demand for prosthetics & orthotics. The elderly population frequently utilizes orthopedic solutions due to increased prevalence of osteoporosis and osteopenia. For instance, according to the World Health Organization (WHO), globally, people aged 60 years or above are expected to double by 2050, increasing from 1.0 billion in 2020 to 2.1 billion in 2050. Thus, the increasing geriatric population boosts demand for various orthopedic solutions.
Prominent players in the market are involved in various strategic initiatives, such as acquisitions, product launches, and collaborations, to gain a competitive edge in the market. For instance, in October 2023, Blatchford, a prosthetics manufacturer company, Tectus, an orthotic device that helps people with partial lower limb paralysis to walk more efficiently, comfortably, and naturally with increased safety. Furthermore, in March 2023, Fabtech Systems, a prosthetic and orthotic solutions provide, partnered with OPIE Software, a clinical practice management software provider, to offer its products to customers using the OPIE system.
Prosthetics And Orthotics Market Report Highlights:
- By product type, the orthotics segment accounted for the largest revenue share of 60% in 2024 due to rising incidence of falls and increasing prevalence of paralysis.
- Prosthetics segmentin product type is expected to show substantial growth during the forecast period. Growing cases of diabetes-related amputations across the globe fuel the segment's growth.
- In 2024, North America dominated the overall market with a revenue share of 37.0% owing to presence of leading market players, advanced healthcare facilities, and growing incidence of orthopedic disorders
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Segment scope
- 1.1.2. Regional scope
- 1.1.3. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.7. Research Assumptions
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Prosthetics And Orthotics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. Prosthetics and orthotics: Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTLE Analysis
Chapter 4. Prosthetics And Orthotics Market Segment Analysis, By Product, 2018 - 2030 (USD Million)
- 4.1. Definition and Scope
- 4.2. Product Market Share Analysis, 2024 & 2030
- 4.3. Segment Dashboard
- 4.4. Global prosthetics and orthotics market, by product, 2018 to 2030
- 4.5. Orthotics
- 4.5.1. Orthotics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.2. Upper limb
- 4.5.2.1. Upper limb orthotics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.3. Lower extremity
- 4.5.3.1. Lower extremity prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5.4. Spinal
- 4.5.4.1. Spinal market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6. Prosthetics
- 4.6.1. Prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.2. Upper extremity prosthetics
- 4.6.2.1. Upper extremity prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.3. Lower extremity prosthetics
- 4.6.3.1. Lower extremity prosthetics market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.4. Liners
- 4.6.4.1. Liners market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.5. Sockets
- 4.6.5.1. Sockets market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.6.6. Modular components
- 4.6.6.1. Modular components market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Prosthetics And Orthotics Market Segment Analysis, By Region, By Product, By Material, By End Use, 2018 - 2030 (USD Million)
- 5.1. Regional Market Share Analysis, 2024 & 2030
- 5.2. Regional Market Dashboard
- 5.3. Regional Market Snapshot
- 5.4. Prosthetics And Orthotics Market Share by Region, 2024 & 2030:
- 5.5. North America
- 5.5.1. North America prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.5.2. U.S.
- 5.5.2.1. U.S. prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.5.3. Canada
- 5.5.3.1. Canada prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.5.4. Mexico
- 5.5.4.1. Mexico prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6. Europe
- 5.6.1. Europe prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.2. UK
- 5.6.2.1. UK prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.3. Germany
- 5.6.3.1. Germany prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.4. France
- 5.6.4.1. France prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.5. Italy
- 5.6.5.1. Italy prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.6. Spain
- 5.6.6.1. Spain prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.7. Norway
- 5.6.7.1. Norway prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.8. Sweden
- 5.6.8.1. Sweden prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.6.9. Denmark
- 5.6.9.1. Denmark prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.7. Asia Pacific
- 5.7.1. Japan
- 5.7.1.1. Japan prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.7.2. China
- 5.7.2.1. China prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.7.3. India
- 5.7.3.1. India prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.7.4. Australia
- 5.7.4.1. Australia prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.7.5. South Korea
- 5.7.5.1. South Korea prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.7.6. Thailand
- 5.7.6.1. Thailand prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.8. Latin America
- 5.8.1. Brazil
- 5.8.1.1. Brazil prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.8.2. Argentina
- 5.8.2.1. Argentina prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.9. MEA
- 5.9.1. South Africa
- 5.9.1.1. South Africa prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.9.2. Saudi Arabia
- 5.9.2.1. Saudi Arabia prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.9.3. UAE
- 5.9.3.1. UAE prosthetics and orthotics market, 2018 - 2030 (USD Million)
- 5.9.4. Kuwait
- 5.9.4.1. Kuwait prosthetics and orthotics market, 2018 - 2030 (USD Million)
Chapter 6. Competitive Landscape
- 6.1. Recent Developments & Impact Analysis, By Key Market Participants
- 6.2. Company Categorization
- 6.3. Company Profiles
- 6.3.1. Ossur
- 6.3.1.1. Company overview
- 6.3.1.2. Financial performance
- 6.3.1.3. Product benchmarking
- 6.3.1.4. Strategic initiatives
- 6.3.2. Blatchford Limited
- 6.3.2.1. Company overview
- 6.3.2.2. Financial performance
- 6.3.2.3. Product benchmarking
- 6.3.2.4. Strategic initiatives
- 6.3.3. Fillauer LLC
- 6.3.3.1. Company overview
- 6.3.3.2. Financial performance
- 6.3.3.3. Product benchmarking
- 6.3.3.4. Strategic initiatives
- 6.3.4. Ottobock
- 6.3.4.1. Company overview
- 6.3.4.2. Financial performance
- 6.3.4.3. Product benchmarking
- 6.3.4.4. Strategic initiatives
- 6.3.5. WillowWood Global LLC.
- 6.3.5.1. Company overview
- 6.3.5.2. Financial performance
- 6.3.5.3. Product benchmarking
- 6.3.5.4. Strategic initiatives
- 6.3.6. Ultraflex Systems Inc.
- 6.3.6.1. Company overview
- 6.3.6.2. Financial performance
- 6.3.6.3. Product benchmarking
- 6.3.6.4. Strategic initiatives
- 6.3.7. Steeper Group
- 6.3.7.1. Company overview
- 6.3.7.2. Financial performance
- 6.3.7.3. Product benchmarking
- 6.3.7.4. Strategic initiatives
- 6.3.8. Bauerfeind
- 6.3.8.1. Company overview
- 6.3.8.2. Financial performance
- 6.3.8.3. Product benchmarking
- 6.3.8.4. Strategic initiatives
- 6.3.9. Aether Biomedical
- 6.3.9.1. Company overview
- 6.3.9.2. Financial performance
- 6.3.9.3. Product benchmarking
- 6.3.9.4. Strategic initiatives
- 6.3.10. Mobius Bionics
- 6.3.10.1. Company overview
- 6.3.10.2. Financial performance
- 6.3.10.3. Product benchmarking
- 6.3.10.4. Strategic initiatives